Marpai Q3: $360K Cash Left, Going Concern Doubt Reiterated
MRAI has more than doubled off its 52-week low of $0.215 on light trading volume (0.3× avg).
Summary
Marpai reported a $3.3 million Q3 loss with only $360 thousand of unrestricted cash and reiterated going concern doubt, leaving the company dependent on another dilutive raise.
Key Events · Earnings and Guidance · MRAI
-
Going Concern Doubt Reiterated
Management determined liquidity conditions raise substantial doubt about the ability to continue as a going concern through twelve months from issuance, with only $360 thousand of unrestricted cash at September 30, 2026.
-
Q3 Loss Narrows Slightly
Net loss was $3.286 million in Q3 2026 versus $3.494 million a year earlier; nine-month net loss was $11.052 million on revenue of $13.034 million, down 7.6% from $14.111 million.
-
Cash Burn Outpaces Financing
Operating cash use was $11.6 million for the nine months, offset by $12.1 million of gross preferred proceeds, a $2.0 million vendor advance and $1.0 million of related-party advances; unrestricted cash fell to $360 thousand from $133 thousand at year-end only because of the raise.
-
Preferred Converts Into 12.1M Shares
The 12,100 Series A preferred shares sold at $1,000 each convert at $1.00 into 12,100,000 common shares, versus 26,879,834 common shares outstanding at September 30, 2026, and carry an 8% PIK dividend ($162 thousand accrued).
Analysis · MRAI · Industrial Applications And Services
With just $360 thousand of unrestricted cash at September 30, 2026, a $11.1 million nine-month net loss and $11.6 million of operating cash burn, management states this raises substantial doubt about the company's ability to continue as a going concern for twelve months. The $12.1 million Series A preferred raise in July bought time, but $2.45 million of it immediately went to AXA, and the preferred converts at $1.00 into 12.1 million common shares—roughly 45% of the 26.9 million shares outstanding—so the equity is heavily diluted. Revenue is shrinking on a nine-month basis ($13.0M vs $14.1M) even as Q3 ticked up 9.6%, and the AXA obligation steps up to $5.0 million in 2028 and about $22.3 million in 2029. Another capital raise is required, and the filing itself warns any debt or equity transaction may cause significant dilution.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MRAI was trading at $2.28 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $61.3M. The 52-week trading range was $0.22 to $4.16. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.